BRYJA, Vítězslav, Pavlína JANOVSKÁ, Michaela GREGOROVÁ, Václav NĚMEC, PrashantKumar KHIRSARIYA and Kamil PARUCH. 백혈병, 림프종 및 고형 종양의 치료에 사용하기 위한 4-(1H-이미다졸-5-일)-1H-피롤로[2,3-b]피리딘 (4—(1H— IMIDAZOL— 5— YL) -1H-PYRROLO (2, 3-B) PYRIDINES FOR USE IN THE TREATMENT OF LEUKAEMIAS, LYMPHOMAS AND SOLID TUMORS). 2022.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name 백혈병, 림프종 및 고형 종양의 치료에 사용하기 위한 4-(1H-이미다졸-5-일)-1H-피롤로[2,3-b]피리딘
Name (in English) 4—(1H— IMIDAZOL— 5— YL) -1H-PYRROLO (2, 3-B) PYRIDINES FOR USE IN THE TREATMENT OF LEUKAEMIAS, LYMPHOMAS AND SOLID TUMORS
Authors BRYJA, Vítězslav (203 Czech Republic, guarantor, belonging to the institution), Pavlína JANOVSKÁ (203 Czech Republic, belonging to the institution), Michaela GREGOROVÁ (203 Czech Republic, belonging to the institution), Václav NĚMEC (203 Czech Republic, belonging to the institution), PrashantKumar KHIRSARIYA (356 India, belonging to the institution) and Kamil PARUCH (203 Czech Republic, belonging to the institution).
Edition Number: KR10-2465111, Publisher: Korean Intellectual Property Office, Place of publication: Cheongsa-ro, Seo-gu, Daejeon, Owner's name: Masarykova univerzita, 2022.
Other information
Original language Korean
Type of outcome Patent
Field of Study 30107 Medicinal chemistry
Country of publisher Republic of Korea
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14310/22:00127218
Organization unit Faculty of Science
Keywords in English lymphomas; leukaemia; solid tumors
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 23/11/2022 08:41.
Abstract
본 발명은 림프종, 백혈병 및 고형 종양을 치료하는데 유용한 새로운 4-(1H-이미다졸-5-일)-1H-피롤로[2,3-b]피리딘 화합물에 관한 것이다.
Abstract (in English)
The invention relates to the lymphatic tumor, the leukemia, and new 4 - (1H- imidazole -5 -yl) -1H- pyrollo [2,3-b] pyridine compound which is useful the solidity tumor is cured.
Links
ED3.1.00/14.0324, research and development projectName: Nové biotechnologie pro medicínu
LM2015063, research and development projectName: Národní infrastruktura chemické biologie (Acronym: CZ-­OPENSCREEN)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/31/53609/2016, interní kód MUName: Analýza nových inhibitorů kasein kinázy 1 pro léčbu chronické lymfocytární leukémie
Investor: Masaryk University
PrintDisplayed: 1/10/2024 09:27